2021
DOI: 10.1016/j.pan.2021.05.232
|View full text |Cite
|
Sign up to set email alerts
|

A dual inhibitor (Metavert) of GSK3B and HDACs in combination with chemotherapeutics improve therapy efficacy in pancreatic cancer cells and human PDAC organoids

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles